HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Immunohistochemical studies of a variant of congenital muscular dystrophy].

Abstract
Three Japanese patients from 2 families had a phenotype indistinguishable from that of Fukuyama-type congenital muscular dystrophy (FCMD). A full mutational analysis of the fukutin gene, however, revealed neither a 3 kb insertion (the Japanese founder mutation) nor a point mutation. A RT-PCR analysis of one of the patients revealed a normal expression of the fukutin transcript, suggesting that they have a new variant of CMD. An immunohistochemical analysis of the muscle of one case showed that the immunoreaction to alpha-dystroglycan (DG) was barely detectable on the surface membranes of muscle fibers. Immunoreactions to beta-DG, dystrophin, laminin alpha-2 chain and sarcoglycan were normal. These findings raise the possibility that the abnormality of alpha-DG is integral to the pathology seen in this variant of CMD. Analysis of POMGnT1 gene, which is causative of muscle-eye-brain disease, revealed no mutation in this case.
AuthorsMieko Yoshioka, Kazuma Sugie, Ichizo Nishino, Tatsushi Toda
JournalNo to hattatsu = Brain and development (No To Hattatsu) Vol. 36 Issue 1 Pg. 55-9 (Jan 2004) ISSN: 0029-0831 [Print] Japan
PMID14737865 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Cytoskeletal Proteins
  • DAG1 protein, human
  • FKTN protein, human
  • Membrane Glycoproteins
  • Membrane Proteins
  • Proteins
  • Dystroglycans
  • N-Acetylglucosaminyltransferases
  • protein O-mannose beta-1,2-N-acetylglucosaminyltransferase
Topics
  • Child, Preschool
  • Cytoskeletal Proteins (deficiency)
  • Dystroglycans
  • Humans
  • Immunohistochemistry
  • Male
  • Membrane Glycoproteins (deficiency)
  • Membrane Proteins
  • Muscle, Skeletal (metabolism)
  • Muscular Dystrophies (congenital, etiology)
  • N-Acetylglucosaminyltransferases
  • Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: